Retreatment with sunitinib in patients with metastatic (spread) kidney cancer.

Registry ID

EUCTR2012-002891-15

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

VU University Medical Center

Start date

2012-09-18

Completion date

2017-04-20

Last update

2026-08-16

Conditions

• Metastatic renal cell carcinoma

Summary

To investigate the proportion of patients that is progression-free at 3 months upon retreatment with sunitinib.

Locations

• , , Netherlands

View on source registry